治疗期间CT成像改善局部晚期头颈癌患者的影像组学模型
研究比较基于治疗前CT与治疗第2周CT的影像组学风险模型对78例接受根治性放化疗的头颈鳞癌患者的预后预测性能。第2周CT模型预测局部区域肿瘤控制的C-Index为0.79,优于治疗前CT的0.65,Kaplan-Meier风险分层亦有改善(p=0.002 vs p=0.063)。作者认为治疗期间成像有望改善影像组学风险模型以用于临床治疗适应。
要点
- 第2周CT影像组学模型预测LRC的C-Index为0.79,治疗前CT为0.65。
- 基于第2周CT的风险分层对LRC有改善(p=0.002),治疗前CT为p=0.063。
- 作者认为治疗期间成像有望改善影像组学风险模型以用于临床治疗适应。
核心结论
- 作者认为,纳入治疗期间的成像可能是改善影像组学风险模型的一种有前景的方式,用于临床治疗适应,即选择可能从剂量调整中获益的患者。
研究设计与样本
- 收集78例接受根治性放化疗的头颈鳞状细胞癌患者的治疗计划CT和第2周CT扫描。
- 从每幅图像中提取1538个影像特征。
- 使用6种特征选择方法和6种机器学习算法构建局部区域肿瘤控制(LRC)和总生存(OS)的预后模型。
- 使用一致性指数(C-Index)评估预后性能,并通过log-rank检验评估风险分层后LRC和OS的差异。
主要发现
- 预测LRC的影像组学风险模型使用第2周CT扫描时性能改善(C-Index:0.79),相比之下治疗前CT扫描为C-Index:0.65。
- Kaplan-Meier分析证实,基于第2周CT的风险分层对LRC有改善(p = 0.002),相比治疗前CT(p = 0.063)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: The development of radiomic risk models to predict clinical outcome is usually based on pre-treatment imaging, such as computed tomography (CT) scans used for radiation treatment planning. Imaging data acquired during the course of treatment may improve their prognostic performance. We compared the performance of radiomic risk models based on the pre-treatment CT and CT scans acquired in the second week of therapy. MATERIAL AND METHODS: Treatment planning and second week CT scans of 78 head and neck squamous cell carcinoma patients treated with primary radiochemotherapy were collected. 1538 image features were extracted from each image. Prognostic models for loco-regional tumour control (LRC) and overall survival (OS) were built using 6 feature selection methods and 6 machine learning algorithms. Prognostic performance was assessed using the concordance index (C-Index). Furthermore, patients were stratified into risk groups and differences in LRC and OS were evaluated by log-rank tests. RESULTS: The performance of radiomic risk model in predicting LRC was improved using the second week CT scans (C-Index: 0.79), in comparison to the pre-treatment CT scans (C-Index: 0.65). This was confirmed by Kaplan-Meier analyses, in which risk stratification based on the second week CT could be improved for LRC (p = 0.002) compared to pre-treatment CT (p = 0.063). CONCLUSION: Incorporation of imaging during treatment may be a promising way to improve radiomic risk models for clinical treatment adaption, i.e., to select patients that may benefit from dose modification.
引用
- Leger S, Zwanenburg A, Pilz K, et al. CT imaging during treatment improves radiomic models for patients with locally advanced head and neck cancer. Radiother Oncol. 2018. PMID: 30087056. doi:10.1016/j.radonc.2018.07.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。